USANA Health Sciences (USNA) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

USANA Health Sciences

NYSE•Consumer Defensive•Packaged Foods

$14.96+0.53(0.04%)Market closed

Market Cap

$265.09M

P/S

0.3x

P/B

0.5x

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

How this company scores

AverageMetricSide Score: 46/100

Strongest: Balance Sheet & Red Flags (15/25); weakest: Profitability (8/25).

Profitability8/25

Growth11/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality12/25

Strengths

Long cash runwayInterest easily coveredConsistent growthNet cash position

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 35.0x5y range 13.3x – 35.0x

Currently above its 19-quarter median.

P/S · 0.3x5y range 0.3x – 1.7x

Currently below its 20-quarter median.

P/B · 0.5x5y range 0.5x – 5.0x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

Operating margins dropped 104.6% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.

Cash Burn

Watch

FCF turned negative in 2 of the last 8 quarters — occasional cash consumption.

Price & Volume

Market Cap $265.09M

Metrics at a Glance

as of July 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $913.36M
Q. Revenue: $223.27M
TTM EBITDA: $31.35M
TTM Op. Income: $-1.08M
Q. Op. Income: $-20.00M
TTM Net Income: $-22.16M
Q. Net Income: $-21.38M
EPS: $-1.16
Shares Out.: $18.49M

$913.36M in TTM revenue grew 1.6% YoY, reaching $223.27M last quarter. TTM EBITDA of $31.35M and TTM operating income of $-1.08M show growth is flowing through to the bottom line. However, net income is negative at $22.16M — growth is not yet reaching the bottom line. Over the past year, TTM revenue is up 2% — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 78.3%
EBITDA Margin: -5.5%
Op. Margin: -9.0%
Net Margin: -9.6%

Op. margin of -9.0% is down 16.0% YoY — costs are rising relative to revenue. Net margin at -9.6% and gross margin of 78.3% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 226% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 0.3x
P/B Ratio: 0.5x

P/S of 0.3x and P/B of 0.5x. P/S is low relative to typical market levels. Across the last 7 quarters, P/E has risen for 4 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $703.21M
Cash: $168.56M
Long-Term Debt: N/A
Book Value: $526.31M
D/E Ratio: N/A
Debt/EBITDA: N/A

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $23.32M
TTM Free Cash Flow: $15.93M
FCF Margin: 1.7%
FCF / Net Income: -0.7

TTM FCF of $15.93M on $23.32M in operating cash flow. The FCF / Net Income ratio of -0.7x means the business consumes cash — it is not yet self-funding. Over the past year, free cash flow is down 69% — an improving trend.